Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer-Reference-Cited by-全球学者库

Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer

Published:2023-09 Issue:9 Volume:13 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Zhang Tingwei¹²³,Wei Yu¹²³,Hong Boon Hao⁴,Sumiyoshi Takayuki⁵,Ong Enya Hui Wen⁴,Zeng Hao⁶,Li Yonghong⁷,Ng Chi‐Fai⁸,Pan Jian¹²³,Fang Bangwei¹²³,Wang Beihe¹²³,Wu Junlong¹²³,Wang Hongkai¹²³,Akamatsu Shusuke⁵⁹,Chua Melvin Lee Kiang⁴¹⁰¹¹,Ye Dingwei¹²³,Zhu Yao¹²³^ORCID

Affiliation:

1. Department of Urology Fudan University Shanghai Cancer Center Shanghai China

2. Department of Oncology Shanghai Medical College Fudan University Shanghai China

3. Shanghai Genitourinary Cancer Institute Shanghai China

4. Division of Medical Sciences National Cancer Centre Singapore Singapore

5. Department of Urology Kyoto University Graduate School of Medicine Kyoto Japan

6. Department of Urology Institute of Urology West China Hospital Sichuan University Chengdu China

7. Department of Urology Sun Yat‐Sen University Cancer Center State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou China

8. Department of Surgery and SH Ho Urology Center Chinese University of Hong Kong Hong Kong Hong Kong

9. Department of Urology Nagoya University Graduate School of Medicine Aichi Japan

10. Department of Head and Neck and Thoracic Cancers Division of Radiation Oncology National Cancer Centre Singapore Singapore

11. Oncology Academic Programme Duke‐NUS Medical School Singapore

Funder

National Natural Science Foundation of China

Program of Shanghai Academic Research Leader

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1411

Reference10 articles.

1. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates

2. Germline Genetic Testing in Prostate Cancer – Further Enrichment in Variant Histologies?

3. DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

4. Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer

5. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019